Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,715 | 3,130 | 1,206 | 2,876 | 462 |
| Cost of Goods | 14,470 | 16,122 | 14,545 | 13,137 | 12,939 |
| Gross Profit | -12,755 | -12,993 | -13,339 | -10,261 | -12,478 |
| Operating Expenses | 5,380 | 5,257 | 6,034 | 5,143 | 6,130 |
| Operating Income | -17,665 | -18,127 | -18,828 | -15,267 | -17,668 |
| Interest Expense | 20 | 11 | 3,802 | 12 | 1,326 |
| Other Income | 1,008 | 5,193 | 287 | 2,333 | 1,210 |
| Pre-tax Income | -16,676 | -12,946 | -22,343 | -12,947 | -17,784 |
| Net Income Continuous | -16,676 | -12,946 | -22,343 | -12,947 | -17,784 |
| Net Income | $-16,676 | $-12,946 | $-22,343 | $-12,947 | $-17,784 |
| EPS Basic Total Ops | -0.51 | -0.39 | -0.68 | -0.40 | -0.55 |
| EPS Basic Continuous Ops | -0.51 | -0.39 | -0.68 | -0.39 | -0.55 |
| EPS Diluted Total Ops | -0.51 | -0.39 | -0.68 | -0.40 | -0.55 |
| EPS Diluted Continuous Ops | -0.51 | -0.39 | -0.68 | -0.39 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.39 | -0.68 | N/A | N/A |
| EBITDA(a) | $-17,021 | $-17,436 | $-18,190 | $-14,560 | $-16,977 |